How have YBGJ shares performed in 2024?

Yubo International Biotech's stock was trading at $0.30 at the beginning of 2024. Since then, YBGJ stock has increased by 216.7% and is now trading at $0.95. View the best growth stocks for 2024 here .

Are investors shorting Yubo International Biotech?

Yubo International Biotech saw a increase in short interest during the month of March. As of March 31st, there was short interest totaling 1,100 shares, an increase of 450.0% from the March 15th total of 200 shares. Based on an average daily trading volume, of 9,100 shares, the days-to-cover ratio is presently 0.1 days. View Yubo International Biotech's Short Interest .

How do I buy shares of Yubo International Biotech?

Shares of YBGJ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

OTCMKTS:YBGJ

Yubo International Biotech (YBGJ) Stock Price, News & Analysis

→ The only accurate crypto trading system I know … (From Weiss Ratings) (Ad)

Free YBGJ Stock Alerts

$0.95

0.00 (0.00%)

(As of 04/18/2024 ET)

Compare

Today's Range: $0.95
▼
$0.95
50-Day Range: $0.30
▼
$1.03
52-Week Range: $0.07
▼
$1.04

Volume: N/A
Average Volume: 2,176 shs
Market Capitalization: $112.27 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Chart Financials SEC Filings Short Interest

Get Yubo International Biotech alerts:

Ad Behind the Markets

Tiny Biotech Stock Wins $75 Billion Patent

A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.

Find out more here >>>

About Yubo International Biotech Stock (OTCMKTS:YBGJ)

Yubo International Biotech Limited, through its subsidiaries, focuses on the research and development, and application of endometrial stem cells. It offers healthcare products for respiratory system, skincare products, hair care products, healthy beverages, and male and female personal care products; and stem cell related services, including cell testing and health management consulting services under the VIVCELL brand. The company is headquartered in Beijing, China.

YBGJ Stock Price History

30 days | 90 days | 365 days | Advanced Chart

YBGJ Stock News Headlines

April 11, 2024 | americanbankingnews.com

Yubo International Biotech Limited (OTCMKTS:YBGJ) Short Interest Update

April 10, 2024 | americanbankingnews.com

Yubo International Biotech (OTCMKTS:YBGJ) Shares Down 3.3%

April 19, 2024 | DTI (Ad)

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

October 1, 2023 | finance.yahoo.com

Promontory Therapeutics Selected as the First International Biotech Company Member of the Paris-Saclay Cancer Cluster

June 15, 2023 | wsj.com

Yubo International Biotech Ltd.

July 18, 2022 | benzinga.com

Yubo International (OTC:YBGJ), Earnings Estimates, EPS, and Revenue

July 18, 2022 | benzinga.com

Yubo International (OTC:YBGJ), Analyst Ratings, Price Targets, Predictions

See More Headlines

Receive YBGJ Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Yubo International Biotech and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today: 4/19/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Sector: Medical
Industry: Electromedical equipment
Sub-Industry: N/A
Current Symbol: OTCMKTS:YBGJ
CUSIP: N/A
CIK: 895464
Web: www.yubogroup.com
Phone: (640) 677-6010
Fax: 516-595-1159
Employees: 20
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-1,200,000.00
Net Margins: -196.21%
Pretax Margin: -87.72%
Return on Equity: N/A
Return on Assets: -59.96%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 0.25
Quick Ratio: 0.18

Sales & Book Value

Annual Sales: $610,000.00
Price / Sales: 184.05
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: 118,180,000
Free Float: 51,433,000
Market Cap: $112.27 million
Optionable: Not Optionable
Beta: 5.50

10 Best Stocks to Own in 2024

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio.

Get This Free Report

Key Executives

Mr. Jun Wang (Age 56)
CEO, President & Director
Comp: $72.41k
Ms. Lina Liu (Age 44)
CFO, Treasurer, Secretary & Director
Comp: $54.31k

Key Competitors

View All Competitors

YBGJ Stock Analysis - Frequently Asked Questions

How have YBGJ shares performed in 2024?: Yubo International Biotech's stock was trading at $0.30 at the beginning of 2024. Since then, YBGJ stock has increased by 216.7% and is now trading at $0.95.
View the best growth stocks for 2024 here.
Are investors shorting Yubo International Biotech?: Yubo International Biotech saw a increase in short interest during the month of March. As of March 31st, there was short interest totaling 1,100 shares, an increase of 450.0% from the March 15th total of 200 shares. Based on an average daily trading volume, of 9,100 shares, the days-to-cover ratio is presently 0.1 days.
View Yubo International Biotech's Short Interest.
How do I buy shares of Yubo International Biotech?: Shares of YBGJ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:YBGJ) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial